Trial Profile
A Phase I, Randomized, Open-Label, Single-Dose Study Assessing the Pharmacokinetics, Safety and Tolerability of Tenofovir Alafenamide, Tenofovir, and Emtricitabine Following Administration of Coformulated Emtricitabine/Tenofovir Alafenamide in Healthy Japanese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2018
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary) ; Cobicistat/darunavir; Darunavir; Ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Japan Tobacco
- 05 Nov 2018 New trial record